Medication info
Nebistole Tablet 5 mg (Nebivolol Hydrochloride)

Nebistole Tablet 5 mg (Nebivolol Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Nebivolol Hydrochloride›5.45mg / 1 tablet
Manufacturer / importer
Ellison Pharmaceutical Co., Ltd.
Appearance
White round tablets
Packaging
30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle
Approval status
Active

MFDS item code 201208083 · Approved 2012.11.09 · Insurance code 620500090

Summary

Main use
Treatment of essential hypertension; adjunctive treatment of chronic heart failure in patients aged 70 years or older
Who takes it
Adults
Adult dose
1. Essential hypertension 1) Adults Administer nebivolol 5mg orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment and may, in some cases, appear after 4 weeks. It may be taken with food. 2) Patients with renal impairment The initial dose is nebivolol 2.5mg orally once daily. If necessary, the daily dose may be increased to 5mg. 3) Elderly patients The initial dose in elderly patients aged 65 years or older is nebivolol 2.5mg once daily. If necessary, the daily dose may be increased to 5mg. Since clinical experience in patients aged 75 years or older is insufficient, administer with careful monitoring. 2. Chronic heart failure 1) Elderly patients aged 70 years or older This drug should be administered to patients with chronic stable heart failure who have had no acute heart failure during the previous 6 weeks, and doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized up to 2 weeks before starting this drug. Taking the patient's condition into account, gradually increase the dose at 1~2-week intervals until the optimal dose for each patient is reached. Begin treatment with nebivolol 1.25mg once daily and, if necessary, increase to 2.5mg once daily, 5mg once daily, and up to 10mg once daily. The maximum daily dose is 10mg. It may be taken with food. 2) Patients with renal impairment Since titration to the maximum tolerated dose is adjusted for each patient, dose adjustment is not required in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine≥250μmol/L), as there is no experience with its use in these patients.

Ingredients

Manufacturer
Ellison Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; adjunctive treatment of chronic heart failure in patients aged 70 years or older

  • Essential hypertension
  • chronic heart failure
View approved original text

This medication is used to manage essential hypertension and also assists in the standard treatment of elderly patients (aged 70 and over) with stable chronic heart failure. It is used to stabilize blood pressure and improve heart function.

How to take

Adult dose

1. Essential hypertension 1) Adults Administer nebivolol 5mg orally once daily at the same time each day. The blood pressure-lowering effect usually appears after 1~2 weeks of treatment and may, in some cases, appear after 4 weeks. It may be taken with food. 2) Patients with renal impairment The initial dose is nebivolol 2.5mg orally once daily. If necessary, the daily dose may be increased to 5mg. 3) Elderly patients The initial dose in elderly patients aged 65 years or older is nebivolol 2.5mg once daily. If necessary, the daily dose may be increased to 5mg. Since clinical experience in patients aged 75 years or older is insufficient, administer with careful monitoring. 2. Chronic heart failure 1) Elderly patients aged 70 years or older This drug should be administered to patients with chronic stable heart failure who have had no acute heart failure during the previous 6 weeks, and doses of cardiovascular medicines such as diuretics, digoxin, ACE inhibitors, and angiotensin II receptor blockers should have been stabilized up to 2 weeks before starting this drug. Taking the patient's condition into account, gradually increase the dose at 1~2-week intervals until the optimal dose for each patient is reached. Begin treatment with nebivolol 1.25mg once daily and, if necessary, increase to 2.5mg once daily, 5mg once daily, and up to 10mg once daily. The maximum daily dose is 10mg. It may be taken with food. 2) Patients with renal impairment Since titration to the maximum tolerated dose is adjusted for each patient, dose adjustment is not required in patients with mild to moderate renal impairment. Do not administer to patients with severe renal impairment (serum creatinine≥250μmol/L), as there is no experience with its use in these patients.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to patients who are allergic to this medication, have bronchial asthma, metabolic acidosis, bradycardia, or severe heart failure or hypotension. Additionally, it is not suitable for patients with severe liver or kidney impairment, pregnant or breastfeeding women, and patients with specific genetic lactose intolerance. Caution is required when administering this medication to patients with chronic lung disease or heart failure, peripheral circulation disorders, thyroid dysfunction, and diabetes. Older adults should also be monitored carefully. During treatment, side effects such as skin rash, changes in vision, abnormal heart rhythms, headaches, dizziness, digestive issues, shortness of breath, and fatigue may occur, so any unusual symptoms should be reported to a healthcare professional immediately. It may be necessary to discontinue this medication before surgery, and abrupt discontinuation can worsen heart problems, so it must be reduced gradually according to a physician's instructions. This medication can interact with other drugs, so special caution is needed when taken in conjunction with calcium channel blockers, antiarrhythmics, central nervous system medications, and diabetes medications. If pregnant or breastfeeding, it should be avoided as it can cause side effects in the fetus or newborn. Safety and effectiveness have not been confirmed for children under 18 years, so it is not recommended. Elderly patients should start at a low dose and be administered cautiously; dosage should be gradually adjusted as necessary. In case of overdose, severe bradycardia, hypotension, and respiratory distress may occur, requiring immediate medical treatment.

Side effects

  • Rash
  • vision impairment
  • bradycardia
  • AV block
  • AV conduction delay
  • hypotension
  • heart failure
  • intermittent claudication
  • headache
  • dizziness
Show 106 more
  • paresthesia
  • depression
  • nightmares
  • syncope
  • diarrhea
  • constipation
  • nausea
  • dyspepsia
  • bloating
  • vomiting
  • dyspnea
  • bronchospasm
  • itching
  • erythematous rash
  • worsening of psoriasis
  • edema
  • fatigue
  • erectile dysfunction
  • vasomotor edema
  • hallucination
  • psychosis
  • confusion
  • cyanosis of the limbs
  • dry eyes
  • Raynaud's phenomenon
  • worsening of heart failure
  • orthostatic hypotension
  • drug intolerance
  • peripheral edema
  • dizziness
  • headache
  • constipation
  • edema
  • nausea
  • chest burning
  • diarrhea
  • insomnia
  • palpitations
  • dyspepsia
  • abdominal pain
  • bradycardia
  • vomiting
  • frequency of urination
  • elevated blood sugar
  • neck pain
  • shoulder pain
  • gastritis
  • chest pain
  • weakness
  • lack of efficacy
  • weight loss
  • cough
  • cold
  • dry cough
  • loss of appetite
  • anxiety
  • back pain
  • increased serum creatinine
  • tinnitus
  • vertigo
  • tremor
  • neuromuscular disease
  • gastroesophageal reflux
  • irritable bowel syndrome
  • thirst
  • gastric ulcer
  • gastrointestinal disorder
  • general weakness
  • facial edema
  • generalized edema
  • upper respiratory infection
  • rhinitis
  • sore throat
  • runny nose
  • restlessness
  • depression
  • drowsiness
  • joint pain
  • flank pain
  • neck stiffness
  • back pain
  • increased BUN
  • bladder discomfort
  • cystitis
  • ureteral stone
  • hematuria
  • diabetes
  • hives
  • athlete's foot
  • sweating
  • tinea corporis
  • hypotension
  • hypertension
  • cerebrovascular disease
  • peripheral vascular disease
  • flushing
  • nosebleed
  • increased ALT
  • increased AST
  • viral infection
  • thyroiditis
  • chronic myeloid leukemia
  • bradycardia
  • hypotension
  • bronchospasm
  • acute heart failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture, and it is important to keep it at a temperature between 1 and 30 degrees Celsius. Maintaining proper storage temperature will safely preserve the medication's effectiveness.

Appearance and packaging

Appearance

White round tablets

Package unit

30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.